OTAC — OceanTech Acquisitions I Share News
0.000.00%
Brief: Oceantech Acquisitions I Following Hearing, Co Received Letter From Nasdaq Stating That Co Regained Compliance Under Mvls Rule
Brief: Oceantech Acquisitions I Says On Sept 13, Got Written Notice From Nasdaq
Brief: Oceantech Acquisitions I Corp Confirms Funding To Extend Period To Consummate Initial Business Combination
Brief: Oceantech Acquisitions I Corp Says On July 24, Submitted Plan To Regain Compliance With Nasdaq Listing Rule 5550(B)(2) For Continued Listing On Nasdaq
Brief: Oceantech Acquisitions I Corp. Confirms Funding To Extend Period To Consummate Initial Business Combination
Brief: Oceantech Acquisitions I Confirms Funding To Extend Period To Consummate Initial Business Combination
Brief: Oceantech Acquisitions I Corp Confirms Funding To Extend Period To Consummate Initial Business Combination
Brief: Regentis Biomaterials Ltd To Become Publicly Listed On Nasdaq Via Business Combination With Oceantech Acquisitions I Corp
Brief: Oceantech Acquisitions I Confirms Funding To Extend Period To Consummate Initial Business Combination
Brief: Oceantech Acquisitions I Corp. Confirms Funding To Extend Period To Consummate Initial Business Combination
Brief: Oceantech Acquisitions I Announces Termination Of Merger Agreement With Majic Wheels
Brief: Oceantech Acquisitions I Corp Confirms Funding To Extend Period To Consummate Initial Business Combination
Brief: Oceantech Acquisitions I Corp Received Notice Of Delisting Or Failure From Nasdaq
Brief: OceanTech Acquisitions Confirms Funding To Extend Period To Consummate Initial Business Combination
Brief: Oceantech Acquisitions Announces Stockholder Approval Of Extension Of Deadline To Complete Business Combination
Brief: Oceantech Acquisitions I Corp Announces Postponement Of Special Meeting Of Shareholders
Brief: Majic Wheels Corp Enters Definitive Merger Agreement With Oceantech Acquisitions I Corp
Brief: Oceantech Announces Termination Of Merger Agreement With Captura Biopharma
Brief: Oceantech Acquisitions I And Captura Biopharma Announce Signing Of Definitive Business Combination Agreement